117 related articles for article (PubMed ID: 28593747)
1. Novel serum metabolomics-based approach by gas chromatography/triple quadrupole mass spectrometry for detection of human skin cancers: Candidate biomarkers.
Fukumoto T; Nishiumi S; Fujiwara S; Yoshida M; Nishigori C
J Dermatol; 2017 Nov; 44(11):1268-1275. PubMed ID: 28593747
[TBL] [Abstract][Full Text] [Related]
2. Investigations in the possibility of early detection of colorectal cancer by gas chromatography/triple-quadrupole mass spectrometry.
Nishiumi S; Kobayashi T; Kawana S; Unno Y; Sakai T; Okamoto K; Yamada Y; Sudo K; Yamaji T; Saito Y; Kanemitsu Y; Okita NT; Saito H; Tsugane S; Azuma T; Ojima N; Yoshida M
Oncotarget; 2017 Mar; 8(10):17115-17126. PubMed ID: 28179577
[TBL] [Abstract][Full Text] [Related]
3. Metabolite Profiles of the Serum of Patients with Non-Small Cell Carcinoma.
Mazzone PJ; Wang XF; Beukemann M; Zhang Q; Seeley M; Mohney R; Holt T; Pappan KL
J Thorac Oncol; 2016 Jan; 11(1):72-8. PubMed ID: 26762741
[TBL] [Abstract][Full Text] [Related]
4. Exploring a Novel Screening Method for Patients with Oral Squamous Cell Carcinoma: A plasma Metabolomics Analysis.
Enomoto Y; Kimoto A; Suzuki H; Nishiumi S; Yoshida M; Komori T
Kobe J Med Sci; 2018 Sep; 64(1):E26-E35. PubMed ID: 30282895
[TBL] [Abstract][Full Text] [Related]
5. Serum and tissue metabolomics of head and neck cancer.
Yonezawa K; Nishiumi S; Kitamoto-Matsuda J; Fujita T; Morimoto K; Yamashita D; Saito M; Otsuki N; Irino Y; Shinohara M; Yoshida M; Nibu K
Cancer Genomics Proteomics; 2013; 10(5):233-8. PubMed ID: 24136976
[TBL] [Abstract][Full Text] [Related]
6. Identification of highly sensitive biomarkers that can aid the early detection of pancreatic cancer using GC/MS/MS-based targeted metabolomics.
Hirata Y; Kobayashi T; Nishiumi S; Yamanaka K; Nakagawa T; Fujigaki S; Iemoto T; Kobayashi M; Okusaka T; Nakamori S; Shimahara M; Ueno T; Tsuchida A; Sata N; Ioka T; Yasunami Y; Kosuge T; Kaneda T; Kato T; Yagihara K; Fujita S; Yamada T; Honda K; Azuma T; Yoshida M
Clin Chim Acta; 2017 May; 468():98-104. PubMed ID: 28215548
[TBL] [Abstract][Full Text] [Related]
7. A pilot study of chromosomal aberrations and epigenetic changes in peripheral blood samples to identify patients with melanoma.
Jakub JW; Grotz TE; Jordan P; Hunter E; Pittelkow M; Ramadass A; Akoulitchev A; Markovic S
Melanoma Res; 2015 Oct; 25(5):406-11. PubMed ID: 26225582
[TBL] [Abstract][Full Text] [Related]
8. Identification of novel biomarkers in the early diagnosis of malignant melanoma by untargeted liquid chromatography coupled to high-resolution mass spectrometry-based metabolomics: a pilot study.
Peña-Martín J; Belén García-Ortega M; Palacios-Ferrer JL; Díaz C; Ángel García M; Boulaiz H; Valdivia J; Jurado JM; Almazan-Fernandez FM; Arias Santiago S; Vicente F; Del Val C; Pérez Del Palacio J; Marchal JA
Br J Dermatol; 2024 Apr; 190(5):740-750. PubMed ID: 38214572
[TBL] [Abstract][Full Text] [Related]
9. Serum metabolomics in oral leukoplakia and oral squamous cell carcinoma.
Sridharan G; Ramani P; Patankar S
J Cancer Res Ther; 2017; 13(3):556-561. PubMed ID: 28862226
[TBL] [Abstract][Full Text] [Related]
10. Pancreatic cancer screening using a multiplatform human serum metabolomics system.
Sakai A; Suzuki M; Kobayashi T; Nishiumi S; Yamanaka K; Hirata Y; Nakagawa T; Azuma T; Yoshida M
Biomark Med; 2016 Jun; 10(6):577-86. PubMed ID: 27171159
[TBL] [Abstract][Full Text] [Related]
11. Serum metabolomics as a novel diagnostic approach for gastrointestinal cancer.
Ikeda A; Nishiumi S; Shinohara M; Yoshie T; Hatano N; Okuno T; Bamba T; Fukusaki E; Takenawa T; Azuma T; Yoshida M
Biomed Chromatogr; 2012 May; 26(5):548-58. PubMed ID: 21773981
[TBL] [Abstract][Full Text] [Related]
12. Urine metabolic fingerprinting using LC-MS and GC-MS reveals metabolite changes in prostate cancer: A pilot study.
Struck-Lewicka W; Kordalewska M; Bujak R; Yumba Mpanga A; Markuszewski M; Jacyna J; Matuszewski M; Kaliszan R; Markuszewski MJ
J Pharm Biomed Anal; 2015; 111():351-61. PubMed ID: 25684700
[TBL] [Abstract][Full Text] [Related]
13. Metabolomic profiling of human serum in lung cancer patients using liquid chromatography/hybrid quadrupole time-of-flight mass spectrometry and gas chromatography/mass spectrometry.
Chen Y; Ma Z; Li A; Li H; Wang B; Zhong J; Min L; Dai L
J Cancer Res Clin Oncol; 2015 Apr; 141(4):705-18. PubMed ID: 25293627
[TBL] [Abstract][Full Text] [Related]
14. Serum metabolomics of laryngeal cancer based on liquid chromatography coupled with quadrupole time-of-flight mass spectrometry.
Zhang X; Hou H; Chen H; Liu Y; Wang A; Hu Q
Biomed Chromatogr; 2018 May; 32(5):e4181. PubMed ID: 29272549
[TBL] [Abstract][Full Text] [Related]
15. Relationships between skin cancers and blood groups--link between non-melanomas and ABO/Rh factors.
Cihan YB; Baykan H; Kavuncuoglu E; Mutlu H; Kucukoglu MB; Ozyurt K; Oguz A
Asian Pac J Cancer Prev; 2013; 14(7):4199-203. PubMed ID: 23991976
[TBL] [Abstract][Full Text] [Related]
16. [Urinary metabolomics study of renal cell carcinoma based on gas chromatography-mass spectrometry].
Zhang L; Li L; Kong H; Zeng F
Nan Fang Yi Ke Da Xue Xue Bao; 2015 May; 35(5):763-6. PubMed ID: 26018279
[TBL] [Abstract][Full Text] [Related]
17. The metabolomic detection of lung cancer biomarkers in sputum.
Cameron SJ; Lewis KE; Beckmann M; Allison GG; Ghosal R; Lewis PD; Mur LA
Lung Cancer; 2016 Apr; 94():88-95. PubMed ID: 26973212
[TBL] [Abstract][Full Text] [Related]
18. [Metabolomics for Biomarker Discovery in Systemic Lupus Erythematosus].
Saegusa J; Kawano S; Morinobu A
Rinsho Byori; 2015 Apr; 63(4):498-505. PubMed ID: 26536784
[TBL] [Abstract][Full Text] [Related]
19. Prognostic biomarkers of cervical squamous cell carcinoma identified via plasma metabolomics.
Zhou H; Li Q; Wang T; Liang H; Wang Y; Duan Y; Song M; Wang Y; Jin H
Medicine (Baltimore); 2019 Jun; 98(26):e16192. PubMed ID: 31261558
[TBL] [Abstract][Full Text] [Related]
20. A plasma metabolomic signature discloses human breast cancer.
Jové M; Collado R; Quiles JL; Ramírez-Tortosa MC; Sol J; Ruiz-Sanjuan M; Fernandez M; de la Torre Cabrera C; Ramírez-Tortosa C; Granados-Principal S; Sánchez-Rovira P; Pamplona R
Oncotarget; 2017 Mar; 8(12):19522-19533. PubMed ID: 28076849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
